Renaissance Technologies
ROIV icon

Renaissance Technologies’s Roivant Sciences ROIV Stock Holding History

Renaissance Technologies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-327,700
Closed -$3.78M – 3857
2024
Q3 		$3.78M Buy
+327,700
New +$3.73M 0.01% 1621
2024
Q2 		– Sell
-1,008,600
Closed -$10.6M – 3891
2024
Q1 		$10.6M Buy
+1,008,600
New +$10.9M 0.02% 960
2022
Q4 		– Sell
-227,400
Closed -$732K – 4353
2022
Q3 		$732K Buy
227,400
+143,100
+170% +$554K ﹤0.01% 2689
2022
Q2 		$343K Buy
+84,300
New +$335K ﹤0.01% 3377
2022
Q1 		– Sell
-33,200
Closed -$335K – 4397
2021
Q4 		$335K Buy
+33,200
New +$276K ﹤0.01% 3292

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Renaissance Technologies's ROIV Position: Q4 2024 in Review

Renaissance Technologies sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 327,700 shares — an estimated $3.78M sold.

Renaissance Technologies first reported a position in ROIV in Q4 2021 and held it in 5 quarters. The position peaked at $10.6M in Q1 2024. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Renaissance Technologies reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 327,700 Roivant Sciences shares in Q4 2024, an estimated $3.78M.
  • Renaissance Technologies first reported a position in Roivant Sciences in Q4 2021 and held it in 5 quarters.
  • Renaissance Technologies's Roivant Sciences position peaked at $10.6M in Q1 2024.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.